Betaxolol (Marlex Pharmaceuticals Inc)
Welcome to the PulseAid listing for the Betaxolol drug offered from Marlex Pharmaceuticals Inc. This Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Marlex Pharmaceuticals Inc |
NON-PROPRIETARY NAME: | Betaxolol |
SUBSTANCE NAME: | BETAXOLOL HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-07-01 |
END MARKETING DATE: | 0000-00-00 |
Betaxolol HUMAN PRESCRIPTION DRUG Details:
Item Description | Betaxolol from Marlex Pharmaceuticals Inc |
LABELER NAME: | Marlex Pharmaceuticals Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/1) |
START MARKETING DATE: | 2016-07-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 10135-623_57968420-5df5-4b0c-ab16-5bb526a908e5 |
PRODUCT NDC: | 10135-623 |
APPLICATION NUMBER: | ANDA075541 |
Other BETAXOLOL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: